C. Schoffelmeer

The Netherlands Cancer Institute

Papers

1

Total Citations

36

H-Index

1

About

C. Schoffelmeer is a clinical researcher whose work centers on improving quality-of-life outcomes for men with low-risk prostate cancer. In a landmark 2013 comparative study, Schoffelmeer investigated how different treatment modalities—brachytherapy, robot-assisted laparoscopic prostatectomy (RALP), and active surveillance (AS)—affect patients’ well-being. Using validated questionnaires, this retrospective analysis provided crucial evidence that active surveillance offers superior quality-of-life preservation compared to more invasive interventions. The study, cited over 35 times, has helped shape clinical decision-making by demonstrating that for low-risk disease, avoiding aggressive treatment can spare patients from unnecessary side effects without compromising oncological safety. Schoffelmeer’s work underscores a patient-centered shift in urological oncology, emphasizing that treatment success must be measured not only by cancer control but by the lived experience of patients. This research remains a key reference for clinicians and researchers navigating the trade-offs between intervention and surveillance in prostate cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
36
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Quality of Life in Patients with Low-Risk Prostate Cancer. A Comparative Retrospective Study: Brachytherapy Versus Robot-Assisted Laparoscopic Prostatectomy Versus Active Surveillance
36 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: The Netherlands Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago